Daiwa Securities Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-229
| Closed | -$10K | – | 1455 |
|
|
2025
Q4 | $10K | Sell |
229
-23
| -9% | -$966 | ﹤0.01% | 1188 |
|
|
2025
Q3 | $10K | Hold |
252
| – | – | ﹤0.01% | 1160 |
|
|
2025
Q2 | $8K | Hold |
252
| – | – | ﹤0.01% | 1128 |
|
|
2025
Q1 | $8K | Hold |
252
| – | – | ﹤0.01% | 1109 |
|
|
2024
Q4 | $10K | Sell |
252
-36
| -13% | -$1.49K | ﹤0.01% | 1123 |
|
|
2024
Q3 | $11K | Buy |
288
+36
| +14% | +$1.45K | ﹤0.01% | 1126 |
|
|
2024
Q2 | $10K | Hold |
252
| – | – | ﹤0.01% | 1164 |
|
|
2024
Q1 | $11K | Hold |
252
| – | – | ﹤0.01% | 1164 |
|
|
2023
Q4 | $12K | Hold |
252
| – | – | ﹤0.01% | 1162 |
|
|
2023
Q3 | $9K | Hold |
252
| – | – | ﹤0.01% | 1134 |
|
|
2023
Q2 | $10K | Hold |
252
| – | – | ﹤0.01% | 1140 |
|
|
2023
Q1 | $9K | Hold |
252
| – | – | ﹤0.01% | 1117 |
|
|
2022
Q4 | $10K | Buy |
252
+54
| +27% | +$1.97K | ﹤0.01% | 1116 |
|
|
2022
Q3 | $7K | Hold |
198
| – | – | ﹤0.01% | 1149 |
|
|
2022
Q2 | $6K | Buy |
198
+57
| +40% | +$1.72K | ﹤0.01% | 1162 |
|
|
2022
Q1 | $4K | Hold |
141
| – | – | ﹤0.01% | 1201 |
|
|
2021
Q4 | $4K | Hold |
141
| – | – | ﹤0.01% | 1231 |
|
|
2021
Q3 | $2K | Buy |
141
+75
| +114% | +$1.3K | ﹤0.01% | 1250 |
|
|
2021
Q2 | $1K | Hold |
66
| – | – | ﹤0.01% | 1222 |
|
|
2021
Q1 | $1K | Hold |
66
| – | – | ﹤0.01% | 1234 |
|
|
2020
Q4 | $1K | Buy |
+66
| New | +$772 | ﹤0.01% | 1213 |
|
|
2019
Q4 | – | Sell |
-165
| Closed | -$1K | – | 1258 |
|
|
2019
Q3 | $1K | Hold |
165
| – | – | ﹤0.01% | 1163 |
|
|
2019
Q2 | $2K | Hold |
165
| – | – | ﹤0.01% | 1155 |
|
|
2019
Q1 | $2K | Buy |
+165
| New | +$1.4K | ﹤0.01% | 1142 |
|
Other funds holding XENE
ACA
DCM
PCH
